1. United States Stocks

  2. •

    Process industries

  3. •

    Chemicals: agricultural
Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc.

OOTC:YTENQ
0.00
USD
0.00
(0.00%)
-24.97EPS
Nov 18Next Earn
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
2,407.09
69,547.9
6,296.67
2,626.64
518.43
400.07
275.62
53.74
53.01
8.08
3.11
2.2
0.18
1.59
Basic EPS, GAAP
-65,515.2
6,100.84
-50,843.33
-27,705.44
-9,094.09
-2,624.78
-3,160
-887.78
-852.03
-103.21
-55.95
-66.25
-43.66
-24.97
Free Cash Flow per Basic Share
-55,111.49
-53,996.64
-45,035
-23,178.24
-8,647.08
-5,231.62
-2,396.5
-850.18
-573.13
-88.33
-47.89
-56.44
-30.55
-11.44
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
66,660.47
79,563.03
33,996.67
8,011.94
4,576.04
2,157.52
1,339.81
545.68
-105.03
68.62
78.79
21.36
-4.95
-9.71
Tangible Book Value per Share
66,660.47
79,563.03
33,996.67
8,011.94
4,576.04
2,157.52
1,339.81
545.68
-105.03
68.62
78.79
21.36
-4.95
-9.71
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Sales/Revenue/Turnover
1
41
4
3
1
1
1
1
1
1
1
- -
- -
1
Operating Margin (%)
-2,727.09
9.49
-755.43
-958.18
-923.63
-884.21
-983.37
-1,676.08
-1,066.5
-1,202.63
-1,904.23
-2,989.11
-24,028.33
-1,554.69
Depreciation Expense
2
1
1
1
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-39
4
-31
-30
-24
-8
-9
-9
-13
-10
-11
-14
-14
-13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-2,721.75
8.77
-807.46
-1,054.79
-1,754.15
-656.08
-995.34
-1,651.98
-1,607.44
-1,277.35
-1,796.58
-3,014.67
-24,091.67
-1,568.15
Working Capital
71
43
19
18
11
5
13
5
9
9
15
3
-3
-6
LT Debt
- -
- -
- -
- -
- -
1
1
6
4
3
3
2
2
1
Total Equity
39
47
20
19
13
6
14
6
-4
10
16
4
-2
-6
Return on Invested Capital (%)
- -
9.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
8.36
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-122.86
8.36
-90.07
-150.71
-148.82
-78.4
-113.61
-99.93
- -
- -
-86.32
-132.83
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
1
2
1
Cash, Cash Equivalents & STI
1
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
6
8
Payables & Accruals
3
2
4
ST Debt
2
2
2
Deferred Revenue
- -
2
2

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-70.13%
-133.17%
-156.43%
Free Cash Flow
-7.15%
3.46%
-12.49%
Net Income, GAAP
-1.21%
11.49%
6.55%
Sales/Revenue/Turnover
-24.39%
-18.49%
-86.67%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-16.35
-16.86
-17
-16.03
-66.25
2023
-18.16
-15.42
-9.95
-6.54
-43.66
2024
-4.77
-5.04
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Oliver P. Peoples
Sector
Process industries
Industry
Chemicals: agricultural
Address
Woburn United States
IPO Date
Nov 10, 2006
Website
yield10bio.com
Similar Companies
UPL Limited (NSE:UPL)
Mosaic Company (The) (NYSE:MOS)
CF Industries Holdings, Inc. (NYSE:CF)
PhosAgro (MOEX:PHOR)
Abou Kir Fertilizers & Chemical Industries Co. (EGX:ABUK)
Misr Fertilizers Production Company MOPCO (EGX:MFPC)
Business
Yield10 Bioscience, Inc. is an agricultural bioscience company focused on developing proprietary genetic traits and elite seed varieties of Camelina sativa for sustainable crop production, renewable biofuels, and nutritional applications. The company develops and offers specialized agricultural products and technologies structured across several key categories: Camelina Seed Products, consisting of proprietary spring and winter Camelina sativa seed varieties bred for enhanced seed yield, accelerated crop establishment, and cold tolerance; Biofuel Feedstock Oils, comprising low-carbon-intensity seed oils engineered as renewable feedstocks for the production of sustainable aviation fuel (SAF) and renewable diesel; Omega-3 Nutritional Oils, encompassing genetically engineered Camelina lines producing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fatty acids designed as sustainable, land-based alternatives to ocean-harvested fish oil for the aquaculture feed, pet nutrition, and human dietary supplement industries; Agronomic and Herbicide Tolerance Traits, providing advanced gene edits and stacked traits conferring resistance to broadleaf and grass herbicides, including glufosinate, to facilitate large-scale commercial weed management; Plant-Based Biomaterials, featuring research and development of Camelina engineered to co-produce polyhydroxyalkanoate (PHA) bioplastics directly in seed; and Trait Discovery and Licensing Services, utilizing the proprietary Gene Ranking Artificial Intelligence Network (GRAIN) computational discovery platform and Trait Factory to identify, validate, and out-license yield-enhancing and carbon-fixation gene targets for third-party commercial crops including canola, soybean, and corn. Founded in 1992 as Metabolix, Inc. and rebranded to Yield10 Bioscience in 2017, the company is headquartered in Woburn, Massachusetts, with field trial operations and grower contracting programs historically spanning North America and research collaborations in the United Kingdom. In recent major developments, the company secured an exclusive global commercial license from Rothamsted Research in 2024 for its omega-3 EPA and DHA Camelina technology, transitioned its public listing from Nasdaq to the OTC Markets under the ticker YTENQ, initiated Chapter 11 bankruptcy proceedings in December 2024, and completed an asset purchase transaction in January 2025 whereby Nufarm Limited acquired substantially all of Yield10's intellectual property, proprietary germplasm, and Camelina research and development assets.